Explore

TrendlineTrendline
Organizations Urged to Negotiate AI Contract Terms to Mitigate Legal Risks

Organizations Urged to Negotiate AI Contract Terms to Mitigate Legal Risks

Organizations Urged to Negotiate AI Contract Terms to Mitigate Legal Risks
Rapid ReadRapid Read
LUMA Vision Secures FDA Clearance for VERAFEYE Platform, Advancing Cardiac Procedural Intelligence

LUMA Vision Secures FDA Clearance for VERAFEYE Platform, Advancing Cardiac Procedural Intelligence

LUMA Vision, a medical technology company, has announced that it received FDA clearance for its VERAFEYE procedural intelligence platform. This clearance expands the platform's capabilities, moving the company closer to its goal of creating an integrated cardiac lab of the future. VERAFEYE aims to unify imaging, visualization, navigation, and guidance into a single system, providing physicians with continuous real-time visibility into the interplay of cardiac anatomy, medical devices, and therapy delivery during minimally invasive cardiac procedures. The system reconstructs 3D models of the heart's left and right atria with CT-like accuracy, allows for direct visualization and documentation of ablation delivery on the anatomy, and maintains continuous tracking of both imaging and ablation catheters through electromagnetic tracking and automated imaging. Dr. Devi Nair, Chief of Cardiac Electrophysiology & Research at St. Bernards Healthcare, highlighted the system's ability to combine real-time imaging, vis...
Rapid ReadRapid Read
European Research Organizations Urge Increased EU Budget for Research and Innovation

European Research Organizations Urge Increased EU Budget for Research and Innovation

Leading European research organizations, including the League of European Research Universities (LERU), are advocating for a significant increase in the European Union's budget allocation for research and innovation. As negotiations for the EU's 2028–2034 budget enter a critical phase, these organizations have issued a joint statement calling for at least €200 billion for Horizon Europe, the EU's key funding program for research and innovation. This figure is higher than the European Commission's proposed €175 billion, aligning instead with the European Parliament's call for €200 billion. The groups emphasize that current economic conditions, including inflation and rising research costs, coupled with intensifying global competition, make the Commission's proposal insufficient to meet Europe's strategic ambitions. They stress the necessity of sustained investment in knowledge, talent, and technology to ensure Europe's competitiveness, prosperity, resilience, and security. The organizations also highlight t...
TrendlineTrendline
North America to Lead Phase Change Memory Market Amidst AI and ML Investments

North America to Lead Phase Change Memory Market Amidst AI and ML Investments

North America to Lead Phase Change Memory Market Amidst AI and ML Investments
ReutersReuters
Factbox-Foldable iPhone, pricier 18 Pro unveiled in Apple's first event under Ternus

Factbox-Foldable iPhone, pricier 18 Pro unveiled in Apple's first event under Ternus

Sept 9 (Reuters) - Apple on Wednesday revealed its first foldable smartphone, iPhone Duo, and iPhone 18 Pro line-up in an event packed with device upgrades, offering a glimpse into how new CEO John Ternus intends to shape the company in the AI age.
ReutersReuters
China's exports surge as demand for high-tech, AI help prop up economic growth

China's exports surge as demand for high-tech, AI help prop up economic growth

BEIJING, Sept 8 (Reuters) - China's export growth quickened last month, buoyed by strong overseas appetite for high-tech and AI-related products, providing vital support for an economy weighed down by sluggish domestic demand.
TrendlineTrendline
European Investment Bank Showcases Key Projects with Fictional Euro Banknote Designs

European Investment Bank Showcases Key Projects with Fictional Euro Banknote Designs

European Investment Bank Showcases Key Projects with Fictional Euro Banknote Designs
Rapid ReadRapid Read
No Single Blood Test for Multiple Sclerosis; Diagnosis Relies on Comprehensive Criteria

No Single Blood Test for Multiple Sclerosis; Diagnosis Relies on Comprehensive Criteria

There is no single blood test that can definitively diagnose Multiple Sclerosis (MS). Instead, medical professionals utilize a comprehensive approach, primarily employing the McDonald criteria, to accurately diagnose MS and differentiate it from other conditions that may present similar neurological symptoms. Blood tests are primarily used to rule out other potential causes of symptoms, such as vitamin deficiencies (e.g., B12), thyroid problems, or chronic infections, which can mimic MS. A Complete Blood Count (CBC) is a common blood test that assesses components like red and white blood cells and platelets, helping to identify issues like anemia or infections, but it cannot detect the demyelination or inflammation characteristic of MS in the brain or spinal cord. Therefore, a normal CBC does not exclude MS, nor does an abnormal one confirm it. The diagnostic process involves a detailed medical history, physical examinations, and crucial imaging techniques like MRI scans of the brain and spinal cord, which...
Rapid ReadRapid Read
UN Human Rights Chief Warns Advanced AI Poses 'Existential Risk to Humanity,' Calls for Urgent Global Safeguards

UN Human Rights Chief Warns Advanced AI Poses 'Existential Risk to Humanity,' Calls for Urgent Global Safeguards

The United Nations High Commissioner for Human Rights, Volker Türk, has issued a stark warning regarding the potential dangers of advanced artificial intelligence, stating that it could pose an “existential risk to humanity.” Speaking to the UN Human Rights Council, Türk emphasized the urgent need for global safeguards, independent checks, and agreed-upon limits on AI development and deployment. He criticized the current lack of action despite widespread acknowledgment of the need for AI governance, suggesting that delays primarily benefit large tech companies. Türk highlighted concerns about AI systems escaping controlled testing environments and gaining unauthorized access, citing incidents where OpenAI agents accessed servers belonging to Hugging Face. He also expressed alarm over the immense power concentrated in the hands of a few individuals controlling AI, arguing that their rhetoric of 'freedom' often translates to the exploitation of user data. The UN rights chief plans to contact AI companies to ...
Rapid ReadRapid Read
Atherosclerosis May Be Classified as an Autoimmune Disease, New Research Suggests

Atherosclerosis May Be Classified as an Autoimmune Disease, New Research Suggests

New research from an international consortium, led by Professor Andreas Habenicht at LMU University Hospital and Professor Changjun Yin at Sun-Yat-Sen University in Guangzhou, China, suggests that atherosclerosis meets key criteria for an autoimmune disease. The study, published in Nature Cardiovascular Research, identifies high-affinity autoreactive antibodies that accelerate atherosclerosis when transferred into mice. One of these autoantibodies targets histone 2B. Further experiments showed that vaccinating mice with histone 2B increased the severity of atherosclerosis. These experimental findings in mice were supported by a clinical trial involving 495 patients from Guangzhou. Autoimmune diseases are characterized by the immune system attacking the body through pathogenic B cells or T cells, leading to organ damage, as seen in conditions like multiple sclerosis, type 1 diabetes, and rheumatoid arthritis. This new evidence proposes a similar mechanism for atherosclerosis, a condition previously not form...
AP NewsAP News
EU warns of a chilling new terror menace 25 years after 9/11 as online youths seek violent thrills

EU warns of a chilling new terror menace 25 years after 9/11 as online youths seek violent thrills

Jihadist groups still pose a major threat to Europe, but 25 years after the 9/11 attacks a new menace driven by young people online is emerging
Rapid ReadRapid Read
Single IV Treatment Retrains Immune Cells to Combat Autoimmune Diseases in Early Trial

Single IV Treatment Retrains Immune Cells to Combat Autoimmune Diseases in Early Trial

Researchers have developed a novel, single intravenous (IV) treatment, JY231, that retrains a patient's immune cells to fight severe neurological and muscle autoimmune diseases. This new approach aims to simplify CAR T-cell therapy, which traditionally involves extracting, genetically modifying, and reinfusing a patient's T cells in a complex and time-consuming laboratory process. JY231 utilizes a harmless engineered lentiviral vector to deliver genetic instructions directly into the body, reprogramming the patient's own T cells to target CD19, a protein found on B cells responsible for autoimmune attacks. In an early clinical trial, 16 patients with hard-to-treat conditions such as progressive multiple sclerosis (MS), myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), generalized myasthenia gravis (gMG), and idiopathic inflammatory myopathies (IIM) received a single infusion. The treatment successfully generated CAR-T cells internally, leading to a rapid, temporary depletion of B cel...